166 related articles for article (PubMed ID: 21168919)
21. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
22. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
23. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.
Domschke K; Hohoff C; Mortensen LS; Roehrs T; Deckert J; Arolt V; Baune BT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):224-8. PubMed ID: 17884271
[TBL] [Abstract][Full Text] [Related]
24. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
25. Genetic studies of drug response and side effects in the STAR*D study, part 1.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
[No Abstract] [Full Text] [Related]
26. Polymorphisms of the glucocorticoid receptor gene and major depression.
van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
[TBL] [Abstract][Full Text] [Related]
27. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
28. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
[TBL] [Abstract][Full Text] [Related]
29. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
[TBL] [Abstract][Full Text] [Related]
30. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
[TBL] [Abstract][Full Text] [Related]
31. Heat-shock protein-70 genes and response to antidepressants in major depression.
Pae CU; Mandelli L; Serretti A; Patkar AA; Kim JJ; Lee CU; Lee SJ; Lee C; De Ronchi D; Paik IH
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1006-11. PubMed ID: 17428599
[TBL] [Abstract][Full Text] [Related]
32. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
[TBL] [Abstract][Full Text] [Related]
33. [5-HT1A gene polymorphisms contributed to antidepressant response in major depression].
Kato M; Fukuda T; Wakeno M; Okugawa G; Takekita Y; Serretti A; Azuma J; Kinoshita T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Feb; 29(1):23-31. PubMed ID: 19326813
[TBL] [Abstract][Full Text] [Related]
34. Genetic studies of drug response and side effects in the STAR*D study, part 2.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
[No Abstract] [Full Text] [Related]
35. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
36. Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Souery D; Serretti A; Calati R; Oswald P; Massat I; Konstantinidis A; Linotte S; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Zohar J; Mendlewicz J
J Clin Psychopharmacol; 2011 Aug; 31(4):512-6. PubMed ID: 21694617
[TBL] [Abstract][Full Text] [Related]
37. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
38. The pharmacogenetics of major depression: past, present, and future.
Laje G; McMahon FJ
Biol Psychiatry; 2007 Dec; 62(11):1205-7. PubMed ID: 17949692
[No Abstract] [Full Text] [Related]
39. Sequence analysis of the serotonin transporter and associations with antidepressant response.
Kraft JB; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
[TBL] [Abstract][Full Text] [Related]
40. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
